1.0
8 Aug 2025
Anonymous employee
Former employee
Boston, MA
Recommend
CEO approval
Business outlook
Pros
Nice product in terms of the cognitive screening tasks
Cons
Weird C-suite. CEO is pretty much in laws with the investor which is why they got funding in the first place but haven’t raised series C. Teams don’t align. Company not doing well and product isn’t hitting the market and selling as they anticipated, and it hasn’t for years. Mostly sales people and very few with actual clinical experience in the company in general, yet they try to sell to clinicians